Inventiva to host a Key Opinion Leader webcast from the AASLD The Liver Meeting Digital Experience 2020 - Seite 2

Presentation #2 :

• Title: “NASH field overview”
  
• Speaker: Prof. Arun Sanyal, Virginia Commonwealth University, Member of Inventiva’s Scientific Advisory Board  
• Topics covered: 
  • Status of the NASH landscape, including lessons learned from recent clinical trial results and interactions with the FDA
  • Comparison of NATIVE Phase IIb clinical trial results with other recent clinical trial results in the NASH field

Presentation #3 :

• Title:  “Management of NASH patients”
  
• Speaker:Prof. Kenneth Cusi, University of Florida, Investigator of the Phase II clinical trial evaluating lanifibranor in patients with TD2M and NAFLD
• Topics covered: Successful management of NASH patients

The details to connect to the webcast are as follows:

• Date: Monday, November 16, 2020  
• Time: 4:00 pm - 5:30 pm (ET) / 10:00 pm - 11:30 pm (CET)  
• Connection details :
  • Option #1 – Webcast: https://edge.media-server.com/mmc/p/uy4bgbir
  • Option #2 – Conference call:
    • France: [phone]
    • Belgium: [phone]
    • Germany: [phone]
    • Netherlands: [phone]
    • Switzerland: [phone]
    • United Kingdom: [phone]
    • United States: [phone]
  •  
    • Access code: 5239026

The presentation document and the link to the webcast (live and replay) will also be available on Inventiva’s website in the “Investors – Investor Presentations” section: http://inventivapharma.com/investors/investor-presentations/.

•••

About the American Association for the Study of Liver Diseases (AASLD)¹

AASLD is the leading organization of scientists and health care professionals committed to preventing and curing liver disease. AASLD fosters research that leads to improved treatment options for millions of liver disease patients. AASLD advances the science and practice of hepatology through educational conferences, training programs, professional publications, and partnerships with government agencies and sister societies.